Medications

Mylan takes takeover bid to Perrigo shareholders

Pharmaceutical company Mylan said Tuesday that it would take its offer to buy Perrigo directly to Perrigo shareholders following refusals by the company's management to engage in merger talks.

Medications

Mylan shareholders approve pursuit of Perrigo

Mylan NV's shareholders approved the company's hostile pursuit of Perrigo Co. and the generic drugmaker hopes to push ahead with a formal offer soon.

Medications

Teva to lift bid for Mylan: report

Israeli pharmaceutical giant Teva plans to increase its bid for rival Mylan and could announce the move as soon as this week, according to a US media report Monday.

Medications

Mylan rebuffs Teva again; calls bid low, insincere

Generic drug company Mylan rejected for the second time Monday a $40.1 billion takeover offer from Israeli pharmaceutical power Teva, just days after Mylan's own bid for rival Perrigo was rebuffed.

Medications

Big pharma mergers: Mylan boosts offer for Perrigo

Generic drug company Mylan increased its offer for over-the-counter giant Perrigo Friday, days after Israel's Teva attempted to head off that deal with its own bid for Mylan.

page 2 from 2